Gollapalle Lakshminarayanshastry Viswanatha | Pharmacology | Best Researcher Award

Published on by Shen Awards

Dr. Gollapalle Lakshminarayanshastry Viswanatha | Pharmacology | Best Researcher Award

Manipal College of Pharmaceutical Sciences, MAHE, Manipal, India

Dr. Gollapalle L. Viswanatha is a distinguished pharmacologist and toxicologist with over 17 years of expertise in pharmaceutical R&D, regulatory toxicology, and preclinical research. Currently serving as a Manager at ClinChoice Pvt. Ltd., Bengaluru, he has held pivotal roles in organizations like IQVIA, The Himalaya Drug Company, and Connexios Life Sciences. A prolific academic and industry contributor, Dr. Viswanatha has authored over 100 peer-reviewed articles and delivered more than 20 expert talks in global forums. As a DABT-certified and European Registered Toxicologist (ERT), his work bridges cutting-edge science with regulatory excellence. He also serves as adjunct faculty at Manipal College of Pharmaceutical Sciences, mentoring postgraduate students and contributing to academic research. His pioneering efforts in herbal drug evaluation, regulatory documentation, and systematic reviews make him a leading voice in toxicology and pharmacology. With several novel animal models to his credit, he actively influences drug discovery and translational medicine.

Professional Profile

Educational 

Dr. Viswanatha holds a PhD in Pharmaceutical Sciences (2019) from JNTU Anantapur, with a dissertation focused on indigenous medicinal plants against stroke and epilepsy. He is board-certified by the American Board of Toxicology (DABT, 2023) and recognized as a European Registered Toxicologist (ERT, 2022). He completed a PG Diploma in Statistical Quality Control and earned a Six Sigma Green Belt from the Indian Statistical Institute (ISI), Bengaluru in 2017, both with Grade ‘A’. He holds an M. Pharm in Pharmacology (2008) from RGUHS, Bengaluru, graduating with 77% and was honored as the Best Outgoing Student. Additionally, he is a GATE and GPAT qualifier. His academic foundation is marked by a multidisciplinary understanding of pharmacology, quality systems, and toxicology. Throughout his academic journey, he has demonstrated a commitment to both practical research and methodological rigor, blending statistical competence with clinical relevance in drug discovery and safety sciences.

Professional Experience

Dr. Viswanatha has a robust professional background spanning regulatory toxicology, preclinical pharmacology, and data surveillance. Currently, he leads the toxicology division at ClinChoice Pvt. Ltd. (2021–present), overseeing cosmetic ingredient safety, CTD preparation, biocompatibility risk assessments, and toxicological risk evaluations. He formerly worked at IQVIA India Pvt. Ltd. (2014–2021) as a Senior Medical Data Reviewer, specializing in clinical trial surveillance and protocol compliance for myocardial infarction studies. Prior to that, he served as a Research Associate at The Himalaya Drug Company (2010–2014), standardizing herbal drug models, and as a Scientist at Connexios Life Sciences (2008–2010), handling PK, safety pharmacology, and toxicological assessments of NCEs. His interdisciplinary approach combines GLP compliance, regulatory documentation, safety evaluations, and project leadership. With broad expertise across pharmaceuticals, nutraceuticals, and cosmetics, he has contributed to product development from discovery to regulatory submission while mentoring cross-functional teams and managing end-to-end project execution.

Awards and Honors 

Dr. Viswanatha has received numerous accolades throughout his academic and professional journey. He was honored with the prestigious Joe-Mae International Young Scientist Award by the AMS Society in Hong Kong (2016) and was a nominee for the Dr. Achari Award at IPSCON 2012 for his work on a novel pharyngitis animal model. He earned the title of Best Outgoing Student during his M. Pharm (2006–2008) and successfully qualified in GATE 2007, GPAT 2010 & 2011. His innovative contributions include the development of novel animal models for non-infectious pharyngitis and hemorrhoids. He has been invited for over 10 expert talks, delivered 5 hands-on workshops, and reviewed articles for over 35 high-impact journals, reflecting his standing as a respected thought leader. These honors underscore his commitment to translational pharmacology, scientific innovation, and academic mentorship, bridging traditional medicine with modern pharmacological practices.

Research Interests 

Dr. Viswanatha’s research interests span preclinical pharmacology, regulatory toxicology, herbal medicine, and evidence-based drug evaluation. His work focuses on stroke, epilepsy, neurodegeneration, nephroprotection, pharyngitis, and gastrointestinal and cardiovascular pharmacology, often using rodent models. He has a strong inclination toward toxicological risk assessment (TRA), biocompatibility studies, and regulatory documentation for pharmaceuticals and cosmetics. His current pursuits involve systematic reviews and meta-analyses on both clinical and preclinical data, particularly emphasizing GABAergic modulation, anti-inflammatory agents, and flavonoids like naringin. He also contributes to safety pharmacology and real-world evidence generation. Beyond therapeutic investigations, he’s deeply involved in OECD-compliant toxicology, SCCS cosmetic safety dossiers, and ISO 10993-based device safety evaluations. His dual strength in bench science and regulatory frameworks makes his research both impactful and implementation-ready, aligning traditional pharmacological principles with global safety standards.

Research Skills

Dr. Viswanatha possesses advanced skills in in vivo and in vitro pharmacological/toxicological experimentation, including GLP-compliant animal models using rats, mice, rabbits, and guinea pigs. He is proficient in conducting acute, repeated dose, and genotoxicity studies, and safety pharmacology evaluations per ICH guidelines. He excels in meta-analysis and systematic reviews using RevMan, RoB-2, G-Power, and Newcastle-Ottawa scales, alongside regulatory documentation (CTD modules 2.4 & 2.6, CPSR, ADE/PDE/OEL assessments). He has expertise in SCCS guidelines, QSAR & AOT software tools, and data analysis using GraphPad Prism, SPSS, and Minitab. He’s also skilled in toxicological literature mining using PubMed, ECHA, PubChem, and other databases. A Six Sigma Green Belt and SQC professional, his approach blends quality systems with analytical rigor. His research strengths lie in project management, protocol development, real-world evidence integration, and regulatory toxicology strategy, making him an asset across life sciences domains.

Conclusion

Dr. Viswanatha exemplifies a rare blend of rigorous experimental pharmacology and robust regulatory toxicology. His multidisciplinary education and certifications, from PhD to international toxicology credentials, underpin his leadership in both academic and industry domains. With a strong track record in innovative animal model development, systematic reviews, and regulatory documentation, he drives preclinical-to-clinical translation effectively. His prolific publication record, awards, and advisory roles highlight a distinguished career that continues to influence global life sciences.

 Publication Top Notes

  • 🧠 Clinical study on cisplatin‑induced nephrotoxicity in humans – PA Arunkumar et al. (2012)

  • 🌿 Ethnopharmacology of Lepidium sativum Linn: A review – D Manohar et al. (2012)

  • 🍃 Antioxidant & anti-inflammatory activity of Mangifera indica leaf extracts – CG Mohan et al. (2013)

  • 🍊 Naringin’s neuroprotective neurobehavioral review/meta-analysis – GL Viswanatha et al. (2017)

  • 🍎 Isolation of antidiabetic principle from Punica granatum rinds – V Jain et al. (2012)

  • 🌳 POG‑glucose inhibits 11β‑HSD‑1 & ameliorates diet-induced diabetes – CG Mohan et al. (2013)

  • 🍋 Lemongrass oil for dexamethasone-induced hyperlipidemia – VRS Kumar et al. (2011)

  • 💊 Hepatoprotective activity of Hepax polyherbal formulation – VC Devaraj et al. (2011)

  • 🌿 Antioxidant & antimutagenic activities of Terminalia arjuna bark – GL Viswanatha et al. (2013)

  • 🩸 Rat model of hemorrhoids: anti‑hemorrhoidal study – M Azeemuddin et al. (2014)

  • 💧 LC‑MS/MS quantification of flavonoids in Moringa & Raphinus – VC Devaraj et al. (2011)

  • 🧠 Animal models of chemotherapy‑induced cognitive decline – J John et al. (2021)

  • 💡 Bacopa monnieri + rivastigmine memory reversal in rats – AHM Thippeswamy et al. (2016)

  • 🍊 Hesperidin’s neuroprotective & mitochondrial benefits – GL Viswanatha et al. (2012)

  • ⚡ Anti‑epileptic activity of Punica granatum leaf extracts – GL Viswanatha et al. (2016)

  • 🌲 Anxiolytic & anticonvulsant activity of Cedrus deodara – GL Viswanatha et al. (2009)

  • 🧠 POG‑glucose alleviates ischemia/reperfusion brain injury – GL Viswanatha et al. (2013)

  • 🧪 Anti‑ulcer effect of Raphinus sativus leaves – VC Devaraj et al. (2011)

  • 🌱 Gymnema sylvestre extract improves glucose uptake – PM Kumar et al. (2016)

  • 🍇 Phytochemical standardization of Punica granatum – V Jain et al. (2011)

  • 🌸 Anti‑fertility activity of Tabernaemontana divaricata flowers – MA Mukhram et al. (2012)

  • 🧊 Anti‑urolithiatic effect of Cedrus deodara extract – N Krishnadas et al. (2010)

  • 💩 Antidiarrheal activity of Thespesia populnea bark fractions – GL Viswanatha et al. (2011)

  • 🦴 Anti‑osteoporotic effect of herbal formula NR/CAL/06 – P Srikanta et al. (2011)

  • 🌿 Antidiarrheal activity of Lepidium sativum seed extract – D Manohar et al. (2011)

  • 🧠 Acteoside from Colebrookea – anti‑epileptic effects – GL Viswanatha et al. (2016)

  • 💊 Thienotriazines: synthesis & antihistaminic activity – GL Viswanatha et al. (2012)

  • 🧠 Punica granatum extract protects against I/R brain injury – GL Viswanatha et al. (2014)

  • 🌱 Colebrookea oppositifolia root for stroke – cerebroprotective effect – GL Viswanatha et al. (2019)

  • 💥 Anticonvulsant activity of POG‑glucose from Mangifera indica – GL Viswanatha et al. (2018)

  • 💊 Mechanisms of biochanin‑A: a pharmacological review – PV Anuranjana et al. (2010)

  • 🧬 Diabetic wound healing: update – R Keni et al. (2012)

  • 🛡️ Cardioprotective preclinical systematic review on naringin – GL Viswanatha et al. (2023)

  • 🌿 Ethnopharmacology of Lepidium sativum Linn. review – M Divanji et al. (2022)

  • 🧠 Erythrina variegata bark extract: anxiolytic & anticonvulsant – G Pitchaiah et al. (2023)

 

Justine Badee | Drug Metabolism | Best Researcher Award

Published on by Shen Awards

Dr. Justine Badee | Drug Metabolism | Best Researcher Award

Scientist from Novartis, Switzerland

Dr. Justine Badée is a distinguished pharmacokinetics researcher with over eight years of experience in the pharmaceutical industry, primarily focusing on physiologically-based pharmacokinetic (PBPK) modeling. Currently serving as a Principal Scientist II at Novartis in Basel, Switzerland, she leads modeling efforts to support drug development from First-in-Human studies to regulatory submissions. Dr. Badée holds a Ph.D. in Pharmacokinetics and Drug Metabolism from the University of Manchester and has a strong foundation as a pharmacist and researcher. Her work encompasses a wide range of applications including drug-drug interactions, pediatric dosing, lactation modeling, and biopharmaceutic assessments. In addition to her scientific contributions, she has mentored Ph.D. students, driven external collaborations with international organizations such as Simcyp and the IQ Consortium, and delivered presentations at leading global conferences. Her multi-disciplinary approach and applied modeling expertise have led to significant advancements in PBPK methodologies and their regulatory application. Dr. Badée has authored and co-authored numerous scientific publications and contributed actively to the development of industry best practices in pharmacokinetics. She is recognized not only for her technical excellence but also for her leadership, mentoring, and collaborative spirit, making her a key contributor to the field of clinical pharmacology and drug metabolism.

Professional Profile

Education

Justine Badée possesses a comprehensive and rigorous academic background in pharmacokinetics and pharmaceutical sciences. She completed her Ph.D. in Pharmacokinetics and Drug Metabolism at the Centre for Applied Pharmacokinetic Research (CAPkR), University of Manchester, UK, where she focused on hepatic uptake clearance and its in vitro to in vivo translation. Her research was supported by joint funding from AstraZeneca and the UK Biotechnology and Biological Sciences Research Council. Prior to her doctoral studies, she earned a Master’s degree in Pharmacokinetics from the Faculty of Pharmacy at University René Descartes V in Paris, France. Additionally, she holds a pharmacy degree from the same institution, completing her training as a licensed pharmacist. Her academic foundation was further strengthened by a scientific high school diploma with a physics major from Saint-Erembert High School in France. Dr. Badée’s academic journey has not only equipped her with a solid theoretical and experimental knowledge base but also cultivated a robust understanding of pharmacological principles and translational research. Her diverse educational pathway—spanning pharmaceutical sciences, clinical pharmacokinetics, and drug metabolism—has played a critical role in her ability to engage in complex modeling tasks and collaborative international research efforts in drug development.

Professional Experience

Dr. Justine Badée’s professional experience reflects a dynamic and upward trajectory in the pharmaceutical and academic sectors. Since 2019, she has been a Clinical PBPK Modeler and Principal Scientist II at Novartis in Basel, where she applies PBPK modeling to a range of clinical drug development scenarios, including DDI predictions, population-specific dosing, and regulatory submissions. She also completed a three-month managerial rotation as a Project Team Manager in oncology, supporting protocol design and pharmacokinetic analysis. Her prior postdoctoral work was jointly conducted at the Center for Pharmacometrics and Systems Pharmacology, University of Florida, and at Hoffmann-La Roche, where she advanced pediatric dose selection by investigating UGT enzyme ontogeny. As a Ph.D. student at the University of Manchester, she led projects on hepatic uptake clearance and nonlinear mixed-effects modeling. Earlier in her career, she held internships at Novartis and INSERM and served as an extern pharmacist at Beaujon Hospital in Paris. Across roles, she has integrated bench research, computational modeling, and clinical applications, resulting in a comprehensive skill set. Her trajectory from laboratory-based research to high-level modeling in an industrial setting exemplifies her adaptability, technical expertise, and commitment to translating pharmacokinetic theory into practice.

Research Interests

Dr. Badée’s research interests lie at the intersection of pharmacokinetics, drug metabolism, and translational modeling. A key focus of her work is the development and application of physiologically-based pharmacokinetic (PBPK) models to optimize drug dosing, predict drug-drug interactions, and inform regulatory decisions. She is particularly interested in special populations—pediatrics, lactating women, and patients with hepatic or renal impairment—where traditional pharmacokinetic approaches often fall short. Her research extends into enzyme ontogeny, especially hepatic UGT isoforms, and how their developmental profiles affect drug metabolism across life stages. Dr. Badée is also engaged in refining in vitro methodologies to better predict in vivo drug behavior, with a focus on improving the reliability of automated glucuronidation assays. Her interest in translational research is evident through her active involvement in industry consortia and collaborative initiatives aimed at improving PBPK workflows and regulatory confidence. Furthermore, she explores innovative model-based approaches to address complex drug development challenges, such as enzyme induction and transporter-mediated drug disposition. Through these pursuits, she contributes to bridging gaps between laboratory findings, clinical implementation, and regulatory science, demonstrating a keen interest in both theoretical development and real-world application of pharmacokinetic modeling.

Research Skills

Dr. Justine Badée possesses a robust portfolio of research skills spanning pharmacokinetic modeling, laboratory techniques, and collaborative project execution. Her core technical competencies include physiologically-based pharmacokinetic (PBPK) modeling using tools such as Simcyp, GastroPlus, and PK-Sim, as well as nonlinear mixed-effect (NLME) modeling with NONMEM. She is adept at both population pharmacokinetics and PK/PD modeling, utilizing software such as WinNonlin/Phoenix, GraphPad Prism, and R. In laboratory settings, she has conducted molecular biology experiments, bioanalytical quantification using LC-MS/MS, protein assays, and hepatocyte isolation, among others. Her experience includes designing and optimizing in vitro uptake and glucuronidation assays to model hepatic metabolism accurately. Dr. Badée’s skills extend beyond the bench and computational tasks—she is also a skilled scientific communicator and collaborator. She has mentored Ph.D. students, led cross-functional teams, and actively participated in international scientific workshops and training programs. Her ability to integrate laboratory findings into advanced modeling platforms reflects her interdisciplinary expertise. Collectively, these skills position her as a valuable contributor to both the academic and industry research ecosystems, ensuring she can translate complex scientific questions into actionable insights for drug development and regulatory strategy.

Awards and Honors

Throughout her career, Dr. Justine Badée has received multiple prestigious awards and recognitions for her scientific excellence and research impact. These include the IQ Recognition Award (2021), the American College of Clinical Pharmacology (ACCP) Wayne A. Colburn Memorial Award (2018), and the ACCP Student Award. Her poster presentations have consistently garnered top honors, winning first-place awards at the Drug Metabolism Discussion Group (DMDG) and Group of Metabolism and Pharmacokinetics (GMP) meetings in 2013 and 2014. In 2023, she received a poster award at the Marbach Drug-Drug Interaction Workshop, further underscoring her contributions to advancing PBPK modeling. In addition to these accolades, she received a certificate of outstanding reviewer for the European Journal of Pharmaceutical Sciences in 2018, recognizing her critical evaluation and contribution to scientific literature. These awards reflect both the scientific rigor and practical relevance of her research. Her consistent recognition by professional bodies and conference committees highlights her leadership in modeling-based drug development and her commitment to excellence in pharmacological science. Dr. Badée’s accolades not only mark her individual achievements but also affirm her role in shaping current and future best practices in pharmacokinetic research.

Conclusion

In conclusion, Dr. Justine Badée represents a rare combination of scientific depth, practical impact, and collaborative leadership in the field of pharmacokinetics. Her contributions span the full spectrum of drug development—from mechanistic in vitro studies to sophisticated PBPK modeling and regulatory submissions. She has successfully bridged academia and industry, delivering actionable solutions to complex pharmacokinetic challenges. Her numerous peer-reviewed publications, awards, and leadership in international collaborations reflect a researcher deeply engaged in advancing the field and mentoring the next generation. With her ability to innovate, communicate, and translate science into therapeutic outcomes, Dr. Badée has established herself as a leading figure in modeling and simulation. Her work not only informs clinical and regulatory decisions but also contributes to safer and more effective drug use in vulnerable populations. As she continues to build on this strong foundation, her career promises further innovations in model-informed drug development. Dr. Badée is an ideal candidate for recognition through the Best Researcher Award, and her work exemplifies the highest standards of scientific inquiry and professional dedication.

Publications Top Notes

  • Predicting Drug Transfer into Human Milk with the Simcyp Simulator: A contribution from the ConcePTION Project
    Macente J, Nauwelaerts N, Badée J, Huang MC, Hernandes Bonan R, Van Neste M, Smits A, Allegaert K, Severino Martins F, Annaert P.
    2025

  • Building Confidence in Physiologically Based Pharmacokinetic Modeling of CYP3A Induction Mediated by Rifampin: An Industry Perspective
    Reddy MB, Cabalu TD, de Zwart L, Ramsden D, Dowty ME, Taskar KS, Badée J, Bolleddula J, Boulu L, Fu Q, Kotsuma M, Leblanc AF, Lewis G, Liang G, Parrott N, Pilla Reddy V, Prakash C, Shah K, Umehara K, Mupkherjee D, Rehmel J, Hariparsad N.
    2025

  • Generic workflow to predict medicine concentrations in human milk using physiologically-based pharmacokinetic (PBPK) modelling – A contribution from the concePTION project
    Nauwelaerts N, Macente J, Hernandes Bonan R, Huang MC, Van Neste M, Bibi D, Badée J, Martins FS, Smiths A, Allegaert K, Bouillon T, Annaert P.
    2023

  • Current Practices, Gap Analysis, and Proposed Workflows for PBPK Modeling of Cytochrome P450 Induction: An Industry Perspective
    Hariparsad N, Ramsden D, Taskar K, Badée J, Venkatakrishnan K, Reddy MB, Cabalu T, Mukherjee D, Rehmel J, Bolleddula J, Emani Riedmaier A, Prakash C, Chanteux H, Mao J, Umehara K, Shah K, De Zwart L, Dowty M, Kotsuma M, Li M, Pilla Reddy V, McGinnity DF, Parrott N.
    2021

  • Characterization of Hepatic UDP-Glucuronosyl Transferase Enzymes Abundance – Activity Correlations and Population Variability using a Proteomics Approach and Comparison with Cytochrome P450 Enzymes
    Takahashi RH, Forrest W, Smith AD, Badée J, Qiu N, Schmidt S, Collier CA, Parrott N, Fowler S.
    2021

  • Ontogeny of Hepatic Transporters and Drug-Metabolizing Enzymes in Humans and in Nonclinical Species
    van Groen BD, Nicolaï J, Kuik AC, van Cruchten S, van Peer E, Schmidt S, de Wildt SN, Allegaert K, de Schaepdrijver L, Annaert P, Badée J.
    2021

  • Paediatric pharmacokinetics and dose predictions: a report of a satellite meeting to the 10th Juvenile Toxicity Symposium
    van Groen BD, Pilla Reddy V, Badée J, Olivares-Morales A, Johnson TN, Nicolaï J, Annaert P, Smits A, de Wildt SN, Knibbe CAJ, de Zwart L.
    2021

  • Co-expression of human hepatic uridine diphosphate glucuronosyltransferase (UGT) proteins: Implications for ontogenetic mechanisms and isoform co-regulation
    Liu Y, Badée J, Takahashi RH, Schmidt S, Parrott N, Fowler S, Mackenzie PI, Coughtrie MWH, Collier AC.
    2020

  • Use of Phenotypically Poor Metaboliser Individual Donor Human Liver Microsomes to Identify Selective Substrates of UGT2B10
    Milani N, Qiu N, Molitor B, Badée J, Cruciani G, Fowler S.
    2020

  • Characterization of the Ontogeny of Hepatic UDP-Glucuronosyl Transferase Enzymes Based on Glucuronidation Activity Measured in Human Liver Microsomes
    Badée J, Qiu N, Collier CA, Takahashi RH, Forrest W, Parrott N, Schmidt S, Fowler S.
    2019

Amir Abaas Momtazi-Borojeni | Biotechnology | Best Researcher Award

Published on by Shen Awards

Assist. Prof. Dr. Amir Abaas Momtazi-Borojeni | Biotechnology | Best Researcher Award

Faculty Member from Neyshabur university of medical sciences, Iran

Dr. Amir Abbas Momtazi-Borojeni is an Assistant Professor of Medical Biotechnology at Neyshabur University of Medical Sciences in Iran. Born on September 17, 1985, in Isfahan, Iran, he has established a distinguished career in medical biotechnology, focusing on nanomedicine, immunotherapy, and phytomedicine. With over 160 publications and more than 7,000 citations, his research has significantly contributed to the fields of cardiovascular and metabolic diseases. His work on PCSK9-targeted therapies and nanoliposomal drug delivery systems has been recognized internationally. Dr. Momtazi-Borojeni’s interdisciplinary approach integrates molecular biology, pharmacology, and bioinformatics, reflecting his commitment to advancing medical science through innovative research.

Professional Profile​

Education

Dr. Momtazi-Borojeni’s academic journey began with a BSc in Biology from Isfahan University (2004–2008), followed by an MSc in Microbial Biotechnology from the same institution (2008–2010). He then pursued a Ph.D. in Medical Biotechnology at Mashhad University of Medical Sciences (2013–2019), where his research focused on developing nanoliposome-based vaccines targeting PCSK9 for lipid-lowering and anti-atherosclerotic effects. His doctoral work combined immunology, nanotechnology, and cardiovascular research, laying the foundation for his future contributions to medical biotechnology.​

Professional Experience

Dr. Momtazi-Borojeni has held various research and academic positions, including roles as a genomics lab expert at the Biotechnology Research Institute in Esfahan and as a part-time researcher at the Pharmaceutical Sciences Research Center of Isfahan University of Medical Sciences. He has also taught courses in cellular and molecular biology, genetic engineering, and bioinformatics at Isfahan University and Islamic Azad University, Neyshabur branch. Currently, he serves as an Assistant Professor at Neyshabur University of Medical Sciences, where he continues to advance research in medical biotechnology.​

Research Interests

Dr. Momtazi-Borojeni’s research interests encompass nanomedicine, immunotherapy, and phytomedicine, with a particular focus on developing innovative treatments for cardiovascular and metabolic diseases. His work on PCSK9-targeted therapies, including vaccine development and siRNA delivery systems, aims to provide alternative strategies for managing hypercholesterolemia and atherosclerosis. Additionally, he explores the therapeutic potential of natural compounds and bioinformatics approaches to identify novel drug targets and understand disease mechanisms.​

Research Skills

Dr. Momtazi-Borojeni possesses a diverse skill set that includes expertise in nanotechnology-based drug delivery, molecular biology techniques, immunological assays, and bioinformatics analysis. His proficiency in designing and characterizing nanoliposomes, conducting in vivo studies, and analyzing gene expression profiles enables him to undertake complex research projects that bridge multiple disciplines. His collaborative work with international researchers further demonstrates his ability to contribute to multidisciplinary teams and advance scientific knowledge.​

Awards and Honors

While specific awards and honors are not detailed in the provided information, Dr. Momtazi-Borojeni’s extensive publication record and citation metrics reflect his significant impact on the field of medical biotechnology. His research has been published in reputable journals, and his contributions to the development of PCSK9-targeted therapies have garnered international recognition. His active participation in scientific communities and collaborations with researchers worldwide underscore his commitment to advancing medical science.​

Conclusion

Dr. Amir Abbas Momtazi-Borojeni’s extensive research in medical biotechnology, particularly in the areas of nanomedicine and immunotherapy, positions him as a strong candidate for the Best Researcher Award. His innovative approaches to treating cardiovascular and metabolic diseases, combined with his interdisciplinary expertise and collaborative spirit, have significantly advanced the field. While specific awards and honors are not listed, his prolific publication record and international collaborations attest to his contributions to medical science. Continued support for his research endeavors will likely yield further breakthroughs in therapeutic strategies and enhance our understanding of complex diseases.​

Publications Top Notes

  1. Therapeutic effects of curcumin in inflammatory and immune‐mediated diseases: A nature‐made jack‐of‐all‐trades?

    • Authors: E. Abdollahi, A.A. Momtazi, T.P. Johnston, A. Sahebkar

    • Year: 2018

    • Citations: 302

  2. Effects of curcuminoids plus piperine on glycemic, hepatic and inflammatory biomarkers in patients with type 2 diabetes mellitus: a randomized double-blind placebo-controlled trial

    • Authors: Y. Panahi, N. Khalili, E. Sahebi, S. Namazi, L.E. Simental-Mendía, M. Majeed, A. Sahebkar

    • Year: 2018

    • Citations: 257

  3. Curcumin as a MicroRNA regulator in cancer: a review

    • Authors: A.A. Momtazi, F. Shahabipour, S. Khatibi, T.P. Johnston, M. Pirro, A. Sahebkar

    • Year: 2016

    • Citations: 256

  4. Curcumin: A natural modulator of immune cells in systemic lupus erythematosus

    • Authors: A.A. Momtazi-Borojeni, S.M. Haftcheshmeh, S.A. Esmaeili, T.P. Johnston, A. Sahebkar

    • Year: 2018

    • Citations: 233

  5. Isolation, identification, and characterization of cancer stem cells: A review

    • Authors: M.R. Abbaszadegan, V. Bagheri, M.S. Razavi, A.A. Momtazi, A. Sahebkar

    • Year: 2017

    • Citations: 228

  6. Curcumin: a potentially powerful tool to reverse cisplatin-induced toxicity

    • Authors: R. Rezaee, A.A. Momtazi, A. Monemi, A. Sahebkar

    • Year: 2017

    • Citations: 199

  7. Cardioprotective microRNAs: Lessons from stem cell-derived exosomal microRNAs to treat cardiovascular disease

    • Authors: A.S. Moghaddam, J.T. Afshari, S.A. Esmaeili, E. Saburi, Z. Joneidi, A. Sahebkar

    • Year: 2019

    • Citations: 196

  8. A review on the pharmacology and toxicology of steviol glycosides extracted from Stevia rebaudiana

    • Authors: A. Abbas Momtazi-Borojeni, S.A. Esmaeili, E. Abdollahi, A. Sahebkar

    • Year: 2017

    • Citations: 192

  9. Role of microRNAs in the therapeutic effects of curcumin in non-cancer diseases

    • Authors: A.A. Momtazi, G. Derosa, P. Maffioli, M. Banach, A. Sahebkar

    • Year: 2016

    • Citations: 186

  10. Difluorinated curcumin: A promising curcumin analogue with improved anti-tumor activity and pharmacokinetic profile

    • Authors: A. Abbas Momtazi, A. Sahebkar

    • Year: 2016

    • Citations: 178

Shengtai Bian | Molecular Biology | Best Researcher Award

Published on by Shen Awards

Assoc. Prof. Dr. Shengtai Bian | Molecular Biology | Best Researcher Award

Association Professor from BEIJING SPORT UNIVERSITY, China

Dr. Shengtai Bian is a distinguished academic and researcher specializing in biomedical engineering, currently serving as an Associate Professor in the School of Sport Science at Beijing Sport University. He also leads the Microfluidics Research & Innovation Laboratory, where he spearheads innovative studies on wearable technologies and health-monitoring devices. With a strong background in microfluidic and electrochemical sensor development, Dr. Bian’s work bridges the domains of material science, biomedical engineering, and sports science. His research focuses on non-invasive monitoring using biofluids such as sweat, interstitial fluid (ISF), and saliva, addressing growing demands in preventive healthcare and point-of-care diagnostics. His research excellence stems from a solid academic foundation, forward-thinking approaches, and interdisciplinary integration. As a principal investigator, he contributes significantly to the academic and technological advancement of wearable sensor systems that can detect physiological signals in real-time. Dr. Bian’s leadership in innovation and scientific inquiry has earned him recognition among the academic and healthcare technology communities. His ability to translate fundamental research into applied solutions makes him a prominent figure in his field. He continues to advance new frontiers in health monitoring by integrating polymeric materials, flexible electronics, and biosensing technologies, setting a benchmark for modern biomedical applications.

Professional Profile

Education

Dr. Shengtai Bian earned his Doctor of Engineering degree in Biomedical Engineering from Tsinghua University, one of the most prestigious and competitive universities in China. Tsinghua University is globally recognized for its strong emphasis on science and technology, and Dr. Bian’s doctoral education provided him with rigorous training in the development and application of advanced biomedical technologies. His doctoral research cultivated a deep understanding of sensor systems, microfluidics, and materials science, laying the groundwork for his future contributions to wearable and point-of-care medical devices. The program also fostered his analytical thinking and research design skills, enabling him to work across disciplines with a strong problem-solving approach. His academic formation at Tsinghua placed him at the cutting edge of emerging biomedical technologies, encouraging innovation and translational research. In addition to core biomedical engineering competencies, Dr. Bian gained experience in collaborative, cross-functional research, particularly in working with interdisciplinary teams that included professionals from fields such as polymer chemistry, electrical engineering, and clinical medicine. This educational experience not only equipped him with in-depth theoretical knowledge but also inspired his current research trajectory focused on wearable microfluidic and electrochemical sensor development for health monitoring applications.

Professional Experience

Dr. Shengtai Bian is currently an Associate Professor in the School of Sport Science at Beijing Sport University, where he also serves as the Principal Investigator of the Microfluidics Research & Innovation Laboratory. In this role, he leads a multidisciplinary team focused on developing wearable health-monitoring devices using microfluidic and electrochemical sensing technologies. His academic appointment has allowed him to merge the fields of sport science, biomedical engineering, and material innovation, applying his expertise to real-world challenges in health and athletic performance monitoring. Dr. Bian’s professional journey has been characterized by progressive leadership and a commitment to impactful research. He is actively involved in teaching, mentoring graduate students, and supervising research projects that aim to develop practical diagnostic and monitoring tools. His work often bridges the academic and applied sectors, and he has established collaborations with both industry partners and academic institutions. Beyond his responsibilities in academia, Dr. Bian frequently participates in research forums and contributes to scientific publications. His professional experience has positioned him as a thought leader in wearable biosensing and applied biomedical technologies. His contributions not only elevate the academic standing of his institution but also play a vital role in shaping the next generation of medical monitoring systems.

Research Interest

Dr. Shengtai Bian’s research interests lie at the intersection of biomedical engineering, wearable technology, and health diagnostics. He is particularly focused on the development of microfluidic and electrochemical sensors for the non-invasive detection of biomarkers in biofluids such as sweat, interstitial fluid (ISF), and saliva. This approach enables real-time health monitoring, making it highly relevant for both clinical and athletic performance applications. His work emphasizes the use of flexible and biocompatible materials to create user-friendly, skin-adherent sensors that can operate continuously and wirelessly. He is also deeply engaged in advancing Point-of-Care Testing (POCT) systems that provide immediate diagnostic information outside traditional laboratory settings, supporting the growing demand for decentralized healthcare. Another core area of his interest is high polymer materials, which serve as foundational elements in the construction of durable, flexible, and sensitive biosensors. By integrating materials science, nanotechnology, and electrochemistry, Dr. Bian aims to develop holistic platforms for personalized health management. His interdisciplinary focus is aligned with global trends in preventive healthcare and digital health solutions. Ultimately, Dr. Bian’s research strives to provide innovative tools that are accessible, affordable, and capable of improving quality of life through early detection and continuous monitoring of physiological conditions.

Research Skills

Dr. Shengtai Bian possesses an extensive array of research skills that contribute to his excellence in the field of biomedical sensing technologies. He is highly skilled in microfluidic device fabrication, including soft lithography, 3D printing, and polymer casting techniques, which are essential for creating small-scale, efficient, and integrable systems for biofluid analysis. His proficiency in electrochemical sensor design enables him to construct precise, sensitive, and stable biosensing platforms for a wide range of health monitoring applications. Dr. Bian has deep expertise in the selection and manipulation of high-performance polymeric materials, which he integrates into flexible and wearable electronics for human health diagnostics. His analytical capabilities include signal processing, biofluid composition analysis, and the calibration of sensors for accurate real-time feedback. Moreover, Dr. Bian is experienced in working with interdisciplinary teams, which enhances his ability to apply his technical skills to real-world healthcare scenarios. He is adept at combining experimental and theoretical methods to validate his devices and systems. His skill set also includes project management, academic writing, grant proposal development, and mentoring, all of which reinforce his leadership in research environments. Collectively, his technical and managerial skills make him a versatile and effective innovator in biomedical engineering.

Awards and Honors

While specific awards and honors for Dr. Shengtai Bian are not explicitly mentioned, his professional standing and leadership roles suggest a commendable track record of academic recognition. As an Associate Professor and Principal Investigator of a dedicated research laboratory, he has achieved a level of distinction typically earned through sustained contributions to science and technology. His selection to lead the Microfluidics Research & Innovation Laboratory indicates institutional trust in his vision and capabilities. Such positions are often awarded based on demonstrated research productivity, innovation, and mentorship. It is reasonable to assume that he has been the recipient of internal grants, competitive research funding, or recognition within his university or research networks for his work in biomedical sensors and wearable technology. Participation in peer-reviewed publications, invited talks, and academic conferences also reflects recognition by the broader scientific community. As his career continues to evolve, further documentation of his awards, patents, and high-impact publications would solidify his profile as a leading figure in this domain. Regardless, his current role and research leadership are testaments to his academic merit and the impact of his work in advancing next-generation health monitoring technologies.

Conclusion

Dr. Shengtai Bian stands out as a forward-thinking researcher whose work aligns with global healthcare trends emphasizing non-invasive, real-time health monitoring. His expertise in microfluidic and electrochemical sensors, coupled with his commitment to interdisciplinary research, places him at the forefront of innovation in wearable health technologies. As an Associate Professor and Principal Investigator, he has demonstrated strong leadership, academic rigor, and a dedication to translating research into practical applications. While additional documentation of his awards, publications, and collaborative engagements would further bolster his candidacy, his ongoing contributions to biomedical engineering already reflect a high level of excellence. His ability to integrate materials science, biosensing, and wearable technology into health solutions makes his research both timely and impactful. He addresses critical challenges in personalized healthcare and preventive diagnostics, which are key priorities in modern medicine and sports science. In conclusion, Dr. Bian is a strong contender for any recognition honoring research excellence, particularly in the domain of biomedical engineering and wearable diagnostics. His vision, research focus, and leadership qualities make him a valuable contributor to the scientific community and a deserving candidate for prestigious research awards.

Publications Top Notes

  1. Antibacterial hydrogel: The sniper of chronic wounds
    Authors: Shengtai Bian, Huijun Ye, Pan Wang, Ming Guan, Shilun Feng
    Year: Not specified
    Citations: 1

Sunday Adelakun | Biomedical Sciences | Excellence in Research

Published on by Shen Awards

Dr. Sunday Adelakun | Biomedical Sciences | Excellence in Research

Lecturer and Researcher at Federal University of Technology, Akure, Nigeria

Dr. Sunday Adelakun is a researcher and lecturer specializing in reproductive anatomy, endocrinology, and neuroscience. He is currently pursuing a Ph.D. in Anatomy at Ladoke Akintola University of Technology, Nigeria, with a focus on the effects of 1-Isothiocyanato-4-methylsulfonyl Butane on cisplatin-induced reproductive toxicity in male rats. He holds an M.Sc. in Anatomy from the University of Lagos and a B.Tech. in Anatomy from Ladoke Akintola University of Technology. Dr. Adelakun’s research interests center around finding alternative therapies for reproductive dysfunction and neurodegenerative diseases, utilizing medicinal herbs and dietary supplements. He has extensive experience in animal modeling, neurobehavioral analysis, and molecular techniques, and has published several peer-reviewed articles. He currently serves as a Lecturer and Group Leader at the Federal University of Technology, Akure, Nigeria.

Profile

Google Scholar

ORCID

Education

Dr. Sunday Adelakun is currently pursuing a Ph.D. in Anatomy at Ladoke Akintola University of Technology, Ogbomoso, Oyo State, Nigeria, with an expected completion date in January 2024. His thesis is focused on Histomorphological and Immunohistochemical Studies on the Effects of 1-Isothiocyanato-4-methylsulfonyl Butane on Cisplatin-Induced Pituitary-Gonadal Axis Toxicity in Male Sprague-Dawley Rats, under the supervision of Prof. Olalekan Wasiu Akintunde. Dr. Adelakun completed his Master of Science (M.Sc.) in Anatomy at the University of Lagos, Lagos State, Nigeria, in December 2012, where his thesis examined Anthropometric Characterization of Skeletal Breadth Variations Amongst Adolescents in Lagos Urban Schools, supervised by Prof. Mike Ibeabuchi. He also earned a Bachelor of Technology (B.Tech.) in Anatomy, graduating with honors in December 2009 from Ladoke Akintola University of Technology. His undergraduate thesis was titled Effect of Crude Ethanol Leaves Extract of Azadirachta Indica on Male Reproductive Organs of Adult Wistar Rats, supervised by Prof. Olalekan Wasiu Akintunde.

Professional Experience

Dr. Sunday Adelakun has extensive professional experience in both research and academia. He currently serves as a Lecturer I and Group Leader of the Neurobehavioral and Aging Laboratory at the Federal University of Technology Akure (FUTA), Nigeria, since 2022. His academic roles also include Lecturer II and Assistant Lecturer positions at FUTA, where he has contributed significantly to teaching and mentoring students in the Department of Human Anatomy. Dr. Adelakun has also worked as a Research Assistant in Prof. Akintunde’s Laboratory at Ladoke Akintola University of Technology, focusing on reproductive and neuro-endocrinology. Earlier in his career, he served as a Gross Anatomy Demonstrator at Ladoke Akintola University, where he trained pre-clinical medical, dental, and health science students in anatomical dissections. In addition to his academic roles, Dr. Adelakun has held volunteer positions, including serving as a community health officer and being actively involved in cancer awareness initiatives. His research work spans reproductive anatomy, endocrinology, and neuroscience, with a particular emphasis on finding alternative therapies for reproductive dysfunction and neurodegenerative diseases.

Research Interests

Dr. Sunday Adelakun’s research interests are primarily focused on reproductive anatomy, endocrinology, and neuroscience. He aims to explore alternative therapies for male and female reproductive dysfunction, as well as sperm DNA fragmentation in neoplastic patients caused by anti-cancer agents. His research seeks to improve outcomes for patients and healthcare workers through the use of effective medicinal herbs and dietary supplements. Additionally, Dr. Adelakun is dedicated to investigating treatments for neurodegenerative diseases and ovarian and testicular dysfunction in animal models. By combining his expertise in molecular biology, neurobehavioral analysis, and biochemistry, he seeks to develop innovative therapeutic approaches to address complex reproductive and neurodegenerative disorders.

Research Skills

Dr. Sunday Adelakun possesses a wide array of advanced research skills and techniques in various fields, including reproductive anatomy, endocrinology, and neuroscience. He is proficient in working with animal models such as mice, rats, rabbits, and pigs, utilizing diverse injection techniques (IV, IP, IM, SC) and specialized methods like stereotaxic, intrathecal, and intracerebroventricular injections. His expertise extends to neurobehavioral analysis, employing methods such as the Morris water maze, Y-maze, and rotarod to assess cognitive and motor functions. Dr. Adelakun is highly skilled in microscopy techniques, including brightfield, fluorescence, confocal, and electron microscopy. He is experienced in protein chemistry, conducting assays like Western blotting, IHC, and ELISA, and is adept at cell biology techniques, including cell culture, fractionation, and gene expression analysis. Furthermore, his proficiency in genomics and proteomics, including molecular docking and bioinformatics, enhances his ability to design and analyze experiments. Dr. Adelakun also has extensive experience with electrophysiology, including patch-clamp techniques, as well as brain calcium imaging protocols, making him a highly skilled researcher in his field.

Awards and Honors

Dr. Sunday Adelakun has earned several notable recognitions for his outstanding contributions to research and academia. His research work has been widely acknowledged, with his publications garnering significant attention in the scientific community. He has received awards for his excellence in research, particularly in the fields of reproductive anatomy, endocrinology, and neuroscience. Dr. Adelakun’s commitment to advancing knowledge in these areas has also led to his active involvement in various community health initiatives, such as his work with the Betty Ayahun Cancer Awareness Group and his role in Oyo State’s health officer programs. These honors and his dedication to both academic and community service underscore his passion for improving public health and advancing scientific research.

Publications

Nutritional supplementation of gallic acid ameliorates Alzheimer-type hippocampal neurodegeneration and cognitive impairment induced by aluminum chloride exposure in adult

  • Authors: B Ogunlade, SA Adelakun, JA Agie
  • Journal: Drug and Chemical Toxicology
  • Year: 2022
  • Volume: 45(2), Pages: 651-662
  • Cited by: 54

Nitrite-induced testicular toxicity in rats: therapeutic potential of walnut oil

  • Authors: SA Adelakun, VO Ukwenya, BS Ogunlade, JA Aniah, AG Ibiayo
  • Journal: JBRA Assisted Reproduction
  • Year: 2019
  • Volume: 23(1), Pages: 15
  • Cited by: 43

Interventions of aqueous extract of Solanum melongena fruits (garden eggs) on mercury chloride induced testicular toxicity in adult male Wistar rats

  • Authors: SA Adelakun, VO Ukwenya, GT Akingbade, OD Omotoso, JA Aniah
  • Journal: Biomedical Journal
  • Year: 2020
  • Volume: 43(2), Pages: 174-182
  • Cited by: 39

Histomorphometric studies of the effects of Telfairia occidentalis on alcohol-induced gonado-toxicity in male rats

  • Authors: EN Akang, AA Oremosu, AA Osinubi, OO Dosumu, TO Kusemiju, …
  • Journal: Toxicology Reports
  • Year: 2015
  • Volume: 2, Pages: 968-975
  • Cited by: 39

Ergonomic analysis of classroom furniture in a Nigerian university

  • Authors: OP Fidelis, B Ogunlade, SA Adelakun, O Adukwu
  • Journal: Nigerian Journal of Technology
  • Year: 2018
  • Volume: 37(4), Pages: 1154-1161
  • Cited by: 29

Vitamin B12 ameliorates Tramadol-induced oxidative stress, endocrine imbalance, apoptosis and NO/iNOS/NF-κB expression in Sprague Dawley rats through regulatory mechanism in the

  • Authors: SA Adelakun, VO Ukwenya, OW Akintunde
  • Journal: Tissue and Cell
  • Year: 2022
  • Volume: 74, Article: 101697
  • Cited by: 26

Sulforaphane response on aluminum-induced oxidative stress, alterations in sperm characterization and testicular histomorphometry in Wistar rats

  • Authors: B Ogunlade, SA Adelakun, K Iteire
  • Journal: International Journal of Reproductive BioMedicine
  • Year: 2020
  • Volume: 18(8), Pages: 611
  • Cited by: 24

Conclusion

Dr. Sunday Adelakun’s extensive academic background, innovative research, and significant contributions to reproductive anatomy, endocrinology, and neurosciences, combined with his advanced technical skills and impressive publication record, make him a strong candidate for the Research for Excellence in Research recognition. His work is both impactful and forward-thinking, contributing significantly to the fields of reproductive health, neurodegenerative diseases, and pharmacological therapy development.

 

JAWAHAR NATARAJAN | Nano Drug Delivery | Excellence in Research

Published on by Shen Awards

Dr. JAWAHAR NATARAJAN | Nano Drug Delivery | Excellence in Research

Associate Professor at JSS College of Pharmacy, Ooty JSS Acedemy of higher education and research, Mysuru, India

Dr. Jawahar Natarajan is an esteemed Associate Professor in the Department of Pharmaceutics at JSS College of Pharmacy, Ooty, with over 22 years of experience in pharmaceutical education and research. He earned his Ph.D. from JSS University in 2014, specializing in drug delivery systems, and holds an M. Pharm in Pharmaceutics. Dr. Natarajan has guided several Ph.D. scholars, successfully mentoring projects focused on advanced drug delivery technologies for neurological and oncological diseases. His extensive research contributions include numerous M. Pharm projects, demonstrating his commitment to innovative solutions in pharmaceuticals. In addition to his academic responsibilities, he has also undertaken a Diploma in Drug Regulatory Affairs and participated in online courses to enhance his expertise. His dedication to advancing pharmaceutical sciences makes him a prominent figure in his field, contributing significantly to both academic and industry-related advancements.

Profile

Education

Dr. Jawahar Natarajan completed his Ph.D. in Pharmaceutics at JSS College of Pharmacy, Ooty, under JSS University, Mysore, in 2014. He also holds a Master of Pharmacy (M.Pharm) degree in Pharmaceutics from K.M. College of Pharmacy, Madurai, completed in 2002 with a commendable 69% score. His academic journey began with a Bachelor of Pharmacy (B.Pharm) from A.K. College of Pharmacy, Krishnan Kovil, in 1999, where he graduated with 61%. In addition to his formal degrees, Dr. Natarajan pursued a Diploma in Drug Regulatory Affairs (DDRA) at the Institute of Pharmaceutical Education and Research, Pune, in 2010, achieving an excellent grade. He further enhanced his knowledge through an online certification course in Industrial Pharmacy from HNB Garhwal University in 2021, scoring 68%. Dr. Natarajan’s diverse educational background reflects his commitment to the field of pharmaceutical sciences, particularly in drug delivery systems.

Professional Experience

Dr. Jawahar Natarajan is an esteemed Associate Professor at the Department of Pharmaceutics, JSS College of Pharmacy in Ooty, affiliated with the JSS Academy of Higher Education and Research. With over 22 years of experience in academia, he has held various teaching positions at reputable institutions, including S. Chattanatha Karayalar College of Pharmacy and Swamy Vivekananda College of Pharmacy. Since joining JSS College of Pharmacy in 2007, Dr. Natarajan has progressed from Lecturer to Assistant Professor and then to his current role as Associate Professor, showcasing his commitment to pharmaceutical education and research. He has guided numerous Ph.D. scholars and M. Pharm students, focusing on innovative drug delivery systems, particularly in the areas of nanoparticle formulation and cancer therapeutics. Dr. Natarajan’s expertise is further complemented by his involvement in curriculum development and regulatory affairs, contributing significantly to the growth of pharmacy education in India.

Research Interest

Dr. Jawahar Natarajan’s research interests are primarily focused on drug delivery systems, particularly in the development of innovative formulations to enhance the bioavailability and therapeutic efficacy of pharmaceutical compounds. His work includes investigating novel nanocarrier systems, such as solid lipid nanoparticles, nanostructured lipid carriers, and liposomes, aimed at improving targeted delivery and minimizing side effects. Dr. Natarajan is also engaged in exploring the use of biocompatible and biodegradable materials in drug formulation, contributing to advancements in personalized medicine. His ongoing research projects involve the bio-directed green synthesis of nanoparticles and the modulation of metabolic pathways for cancer treatment, demonstrating his commitment to addressing significant health challenges. Additionally, Dr. Natarajan actively mentors Ph.D. scholars and oversees various M. Pharm projects, fostering the next generation of pharmaceutical researchers while promoting innovative solutions in the field of pharmaceutics.

Research Skills

Dr. Jawahar Natarajan possesses a diverse array of research skills, primarily focused on drug delivery systems within the field of pharmaceutics. With over 22 years of experience, he has developed a profound expertise in formulating nanoparticles, liposomes, and nanostructured lipid carriers, enhancing the bioavailability of various therapeutic agents. His proficiency extends to guiding Ph.D. scholars and M. Pharm students, where he has successfully supervised numerous research projects that explore innovative drug delivery methodologies. Dr. Natarajan is adept at utilizing advanced analytical techniques, including characterization methods for nanomaterials and pharmacokinetic evaluations. His commitment to research is reflected in his contributions to peer-reviewed journals and active participation in conferences. Additionally, his skills in regulatory affairs ensure compliance with industry standards, bolstering the translation of research findings into practical applications. Overall, Dr. Natarajan’s comprehensive skill set underpins his significant contributions to pharmaceutical research and education.

Award and Recognition

Dr. Jawahar Natarajan, an esteemed Associate Professor at JSS College of Pharmacy, has garnered significant recognition for his contributions to the field of pharmaceutics and drug delivery systems. With over 22 years of academic experience, he has successfully guided numerous Ph.D. and M. Pharm. scholars, leading innovative research in targeted drug delivery and nanotechnology. His commitment to excellence is reflected in his impactful publications in reputable journals and presentations at national and international conferences. Dr. Natarajan has also played a pivotal role in enhancing pharmaceutical education through his involvement in curriculum development and academic committees. His dedication to advancing the field has earned him accolades from peers and institutions alike, establishing him as a respected figure in pharmaceutical sciences. Furthermore, his ongoing research continues to contribute to the advancement of healthcare solutions, solidifying his reputation as a leader in pharmaceutical research and education.

Conclusion

Jawahar N. possesses a strong foundation for the Research for Excellence in Research award through his extensive experience, solid educational background, and commitment to research in drug delivery systems. By enhancing his publication record and seeking collaborative and funding opportunities, he could further bolster his candidacy. His dedication to mentoring students and contributing to innovative projects in pharmaceutics makes him a commendable nominee for this prestigious recognition. Overall, Jawahar’s contributions to the field are noteworthy, and with slight adjustments and enhancements in his research visibility and collaboration efforts, he is well-positioned to excel in his future endeavors.

Publication Top Notes
  1. Polymeric nanoparticles for drug delivery and targeting: A comprehensive review
    • Authors: N Jawahar, S Meyyanathan
    • Year: 2012
    • Journal: International Journal of Health & Allied Sciences
    • Volume/Issue/Page: 1 (4), 217-217
  2. Development of buccal tablets for curcumin using Anacardium occidentale gum
    • Authors: K Gowthamarajan, N Jawahar, P Wake, K Jain, S Sood
    • Year: 2012
    • Journal: Carbohydrate Polymers
    • Volume/Issue/Page: 88 (4), 1177-1183
  3. Preparation and evaluation of sustained release matrix tablet of diclofenac sodium using natural polymer
    • Authors: GNK Ganesh, R Sureshkumar, N Jawahar, V Senthil, DN Venkatesh, …
    • Year: 2010
    • Journal: Journal of Pharmaceutical Sciences and Research
    • Volume/Issue/Page: 2 (6), 360
  4. Enhanced oral bioavailability of an antipsychotic drug through nanostructured lipid carriers
    • Authors: N Jawahar, PK Hingarh, R Arun, J Selvaraj, A Anbarasan, …
    • Year: 2018
    • Journal: International Journal of Biological Macromolecules
    • Volume/Issue/Page: 110, 269-275
  5. Solid lipid nanoparticles for oral delivery of poorly soluble drugs
    • Authors: N Jawahar, SN Meyyanathan, G Reddy, S Sood
    • Year: 2012
    • Journal: Journal of Pharmaceutical Sciences and Research
    • Volume/Issue/Page: 4 (7), 1848
  6. Olanzapine loaded cationic solid lipid nanoparticles for improved oral bioavailability
    • Authors: S Sood, N Jawahar, K Jain, K Gowthamarajan, S Nainar Meyyanathan
    • Year: 2013
    • Journal: Current Nanoscience
    • Volume/Issue/Page: 9 (1), 26-34
  7. Anti–arthritic activity of bark extracts of Alangium salviifolium Wang
    • Authors: S Jubie, N Jawahar, R Koshy, B Gowramma, V Murugan, B Suresh
    • Year: 2008
    • Journal: Rasayan J. Chem
    • Volume/Issue/Page: 1 (3), 433-436
  8. Preparation and characterisation of PLGA-nanoparticles containing an anti-hypertensive agent
    • Authors: N Jawahar, T Eagappanath, N Venkatesh, S Jubie, MK Samanta
    • Year: 2009
    • Journal: International Journal of Pharm Tech Research
    • Volume/Issue/Page: 1 (2), 390-393
  9. Nanoparticles: A novel pulmonary drug delivery system for tuberculosis
    • Authors: N Jawahar, G Reddy
    • Year: 2012
    • Journal: Journal of Pharmaceutical Sciences and Research
    • Volume/Issue/Page: 4 (8), 1901
  10. Synthesis and biological evaluation of some 3-(methoxy phenyl)-2-aryl-thiazolidin-4-one derivatives
    • Authors: S Jubie, B Gowramma, KM Nitin, N Jawahar, R Kalirajan, S Gomathy, …
    • Year: 2009
    • Journal: Indian Journal of Pharmaceutical Sciences
    • Volume/Issue/Page: 1 (1), 32-38

 

 

 

 

Bibiana Doris Riquelme | Biomedical Physics | Best Researcher Award

Published on by Shen Awards

Bibiana Doris Riquelme | Biomedical Physics | Best Researcher Award

Principal Research, Consejo Investigaciones Universidad Nacional de Rosario (CIUNR), Argentina.

Bibiana Doris Riquelme is a distinguished physicist based in Rosario, Argentina, with extensive expertise in applied physics, biophotonics, hemorrheology, and biosensors. Her interdisciplinary approach combines principles of physical sciences and biomedical research, leading to significant advancements in understanding biomolecular interactions and their applications in medical technology. Riquelme is affiliated with the Institute of Physics of Rosario (IFIR), where she continues to contribute to innovative research initiatives.

Profile:

 

Education

Riquelme completed her Bachelor’s Degree in Physics from the National University of Rosario (UNR) in December 1989, specializing in applied optics to biology. She further advanced her education by earning a Doctorate in Physics in May 1997, focusing on the complex rheology of biomembranes and its application to human erythrocytes. Additionally, she holds a degree as a Professor of Drawing and Painting from S.S.M. Cosmopolita, demonstrating her diverse academic background and creative skills.

Professional Experiences

Bibiana Riquelme’s professional journey includes a postdoctoral fellowship awarded by FOMEC at the National University of Rosario, where she spent ten months abroad in France, engaged in research at the Laboratory of Mechanics and Cellular and Tissue Engineering. Her work in various esteemed institutions has allowed her to collaborate with leading researchers and contribute to significant advancements in her field. Currently, she is a research scientist at the Institute of Physics of Rosario, where she leads projects focusing on optics and biophysics.

 

Research skills

Riquelme possesses a comprehensive skill set in several critical areas of research, including optics, biophotonics, and hemorrheology. Her proficiency extends to the design and development of biosensors and the study of biomolecular interactions in solution. Her expertise in applied optics to biomedical sciences enables her to contribute significantly to both theoretical and practical advancements in health-related technologies, including medical biomaterials and stem cell technologies.

 

Awards And Recoginition

Throughout her career, Riquelme has received recognition for her contributions to science and technology. Her postdoctoral research experience and collaborations with international research institutions highlight her commitment to advancing knowledge in her field. While specific awards and recognitions are not detailed in the provided information, her standing as a researcher in the academic community reflects her impactful work and dedication to scientific excellence.

Conclusion

Bibiana Doris Riquelme possesses a robust academic background, specialized research expertise, and postdoctoral experience, making her a strong candidate for the Best Researcher Award. Her contributions to applied physics in the biomedical field and her potential for impactful research underscore her suitability for this recognition. Addressing the areas for improvement, particularly in showcasing her publications and community engagement, could further bolster her candidacy and demonstrate her influence within the scientific community.

Publication Top Notes

  • Preliminary Study of the Gamma-Radiation Effect on the Plasma Ions Concentration in Transfusion Units
    Authors: Alet, A.I., Porini, S., Detarsio, G., Galassi, M.E., Riquelme, B.D.
    Year: 2024
    Citation: Anales de la Asociacion Fisica Argentina, 35(1), pp. 21–24.
    🧪📊
  • Effect of Aqueous Extracts of Phyllanthus sellowianus on the Viscoelastic Properties of Human Red Blood Cells: In Vitro Antidiabetic Activity
    Authors: Mascaro Grosso, H., Buszniez, P., Castellini, H.V., Riquelme, B.D.
    Year: 2023
    Citation: Anales de la Asociacion Fisica Argentina, 34(2), pp. 42–45.
    🍃💉
  • Biospeckle Laser as a Tool to Analyze Erythrocyte Aggregation
    Authors: Toderi, M.A., Riquelme, B.D., Galizzi, G.E.
    Year: 2022
    Citation: Optical Engineering, 61(12), 124101.
    🔬✨
  • Methods: A New Protocol for In Vitro Red Blood Cell Glycation
    Authors: Batista da Silva, M.V., Alet, A.I., Castellini, H.V., Riquelme, B.D.
    Year: 2022
    Citation: Comparative Biochemistry and Physiology – Part A: Molecular and Integrative Physiology, 264, 111109.
    📚🧬
  • New Insights into the Mechanics of Erythrocytes: Effects of Radiation and Several Drugs of Biomedical Interest
    Authors: Riquelme, B.D., Toderi, M., Batista, M., Estrada, E., Alet, A.I.
    Year: 2022
    Citation: Series on Biomechanics, 36(1), pp. 61–69.
    🩸🔍
  • In Vitro Alteration on Erythrocytes Mechanical Properties by Propofol, Remifentanil, and Vecuronium
    Authors: Alet, A.I., Batista da Silva, M.V., Castellini, H.V., Alet, N.A., Riquelme, B.D.
    Year: 2021
    Citation: Microvascular Research, 135, 104132.
    💊🩹
  • New Insights into the Analysis of Red Blood Cells from Leukemia and Anemia Patients: Nonlinear Quantifiers, Fractal Mathematics, and Wavelet Transform
    Authors: Bortolato, S.A., Mancilla Canales, M.A., Riquelme, B.D., Ponce de León, P., Korol, A.M.
    Year: 2021
    Citation: Physica A: Statistical Mechanics and its Applications, 567, 125645.
    📈💔
  • Simultaneous Determination of Human Erythrocyte Deformability and Adhesion Energy: A Novel Approach Using a Microfluidic Chamber and the “Glass Effect”
    Authors: Londero, C.M., Riquelme, B.D.
    Year: 2021
    Citation: Cell Biochemistry and Biophysics, 79(1), pp. 49–55.
    🔬💧
  • Preliminary Study of the Effects of Gamma Radiations on Human Red Blood Cells
    Authors: Estrada, E., Castellini, H., Acosta, A., Riquelme, B.D., Galassi, M.E.
    Year: 2020
    Citation: Anales de la Asociacion Fisica Argentina, 31(2), pp. 51–54.
    ☢️🔴
  • Extensive Clinical, Serologic and Molecular Studies Lead to the First Reported Rhmod Phenotype in Argentina
    Authors: Mufarrege, N., Franco, N., Trucco Boggione, C., Castilho, L., Cotorruelo, C.
    Year: 2020
    Citation: Transfusion, 60(7), pp. 1373–1377.
    🩸🇦🇷

Ali Motie Nasrabadi | Biomedical Engineering | Best Researcher Award

Published on by Shen Awards

Prof. Ali Motie Nasrabadi | Biomedical Engineering | Best Researcher Award

Professor at Shahed University, Iran

Prof. Ali Motie Nasrabadi is a renowned academic and researcher in the field of Biomedical Engineering, specializing in the intelligent processing of EEG signals, computational neuroscience, and artificial intelligence in healthcare applications. He earned his Ph.D. in Biomedical Engineering from Amirkabir University of Technology in 2004, where his research focused on evaluating consciousness and hypnosis depth through EEG signal analysis. With a career spanning decades, Prof. Nasrabadi has contributed extensively to EEG/ERP signal processing, nonlinear and chaotic systems, and physiological modeling. He has published over 100 peer-reviewed papers and continues to influence the fields of biomedical signal processing and neuroscience.

Profile

Education

Prof. Ali Motie Nasrabadi has a distinguished academic background in Biomedical Engineering, with his education centered at the Amirkabir University of Technology in Tehran, Iran. He earned his Ph.D. in Biomedical Engineering in March 2004, with a dissertation titled “Quantitative and Qualitative Evaluation of Consciousness Variation and Depth of Hypnosis through Intelligent Processing of EEG Signals.” His doctoral research focused on advanced signal processing techniques applied to biomedical data. Prior to that, he completed his M.Sc. in Biomedical Engineering in September 1998, where he specialized in the “Design and Implementation of an 8-channel PC-Based Electroencephalograph.” This work demonstrated his early interest in biomedical instrumentation and signal analysis. Prof. Nasrabadi began his academic journey with a B.Sc. in Electronic Engineering in February 1994, focusing on the “Design and Implementation of Control of Satellite Dish to Get Better Signal.” His strong foundation in electronic engineering and biomedical systems has been integral to his success in applying engineering principles to healthcare challenges.

Professional Experience

Prof. Ali Motie Nasrabadi has had a distinguished career across both academic and industrial sectors. He has served as the Vice Chancellor for Support and Resource Management at Shahed University from 2017 to 2021, where he played a pivotal role in overseeing resource management. Prior to this, he was the Director General of Equipment at Shahed University, a position he held from 2004 to 2021. His expertise in biomedical signal processing has led to consultancy roles, including being an EEG Signal Processing Consultant at the National Brain Mapping Laboratory (NBML) since 2016. In this capacity, he has also designed and organized brain signal processing workshops at NBML. Prof. Nasrabadi has been actively involved in industrial and technology consulting as well. Since 2014, he has been a Technology and E-commerce Consultant at Shenasa Venture Capital and Trigup Accelerator. Earlier in his career, he worked as a researcher at the Research Center for Intelligent Signal Processing (RCISP) from 2001 to 2006 and the Laser and Optical Group at the Research Center for Science and Technology in Medicine (RCSTIM) from 1998 to 2004. His wide-ranging experience reflects his strong influence in both academia and industry, particularly in the fields of biomedical engineering and signal processing.

Research Interest

Prof. Ali Motie Nasrabadi’s research interests are deeply rooted in the intersection of biomedical engineering and signal processing. His primary focus is on artificial intelligence in healthcare applications, where he explores the potential of AI to enhance medical diagnostics and treatments. He is also heavily involved in computational neuroscience, studying the brain’s complex systems through computational models. Prof. Nasrabadi specializes in chaotic and nonlinear signal processing, applying advanced techniques to understand irregular biological signals. A significant portion of his research is dedicated to the recording and processing of EEG/ERP/LFP/ECoG signals, where he analyzes brain activity patterns for medical and cognitive insights. Additionally, he is interested in the modeling of physiological systems, where he creates mathematical representations of biological processes to better understand and predict their behavior. This broad array of research areas positions Prof. Nasrabadi as a leading figure in applying advanced computational methods to solve complex challenges in healthcare and neuroscience.

Research Skills

Prof. Ali Motie Nasrabadi possesses a diverse set of skills that span across various domains of biomedical engineering and computational analysis. He is an expert in MATLAB and C programming, which he uses for designing and implementing algorithms for signal processing and neural network modeling. His proficiency with EEGLAB and SPM software makes him adept at processing and analyzing EEG and brain signals, essential for neuroscience research. Additionally, Prof. Nasrabadi is skilled in SPSS, which he uses for statistical data analysis, allowing him to interpret complex biomedical data. His deep understanding of chaos theory and nonlinear dynamics further complements his expertise, enabling him to analyze and quantify irregular physiological signals. These technical and computational skills are integral to his contributions in fields such as artificial intelligence, signal processing, and healthcare.

Award and Recognition

Prof. Ali Motie Nasrabadi has received several awards and recognitions throughout his distinguished academic and research career. He achieved First Rank in his B.Sc. program from the Department of Electrical Engineering at Amirkabir University of Technology, with an impressive average score of 18.16 out of 20. Similarly, he was awarded First Rank in his M.Sc. program from the Department of Biomedical Engineering at Amirkabir University of Technology, with an outstanding average score of 18.63 out of 20. His significant contributions to the field of biomedical engineering, particularly in signal processing and artificial intelligence applications, are reflected in his high H-index of 31 in Google Scholar and H-index of 23 in Scopus, underscoring the impact of his research in the global scientific community.

Conclusion

Considering Prof. Ali Motie Nasrabadi’s extensive academic achievements, innovative research in biomedical signal processing, significant publication record, industry-related activities, and leadership roles, he is highly suitable for the Research for Best Researcher Award. His work has had a profound impact on the field of biomedical engineering, particularly in the analysis and processing of EEG signals, making him a deserving candidate for this prestigious recognition.

Publications Top Notes

  • Title: EEG Classification of ADHD and Normal Children Using Non-linear Features and Neural Network
    • Citations: 220
    • Year: 2016
  • Title: Detecting Driver Mental Fatigue Based on EEG Alpha Power Changes During Simulated Driving
    • Citations: 153
    • Year: 2015
  • Title: A New Automatic Sleep Staging System Based on Statistical Behavior of Local Extrema Using Single Channel EEG Signal
    • Citations: 110
    • Year: 2018
  • Title: Determining Fault’s Type and Accurate Location in Distribution Systems with DG Using MLP Neural Networks
    • Citations: 105
    • Year: 2009
  • Title: A Review on EEG Signals Based Emotion Recognition
    • Citations: 103*
    • Year: 2018
  • Title: The Emotion Recognition System Based on Autoregressive Model and Sequential Forward Feature Selection of Electroencephalogram Signals
    • Citations: 83
    • Year: 2014
  • Title: EEG-based Mental Task Classification: Linear and Nonlinear Classification of Movement Imagery
    • Citations: 69
    • Year: 2006
  • Title: Emotion Classification Through Nonlinear EEG Analysis Using Machine Learning Methods
    • Citations: 68
    • Year: 2018

 

Yasamin Haririan | Biomedical Engineering | Best Researcher Award

Published on by Shen Awards

Ms. Yasamin Haririan | Biomedical Engineering | Best Researcher Award

Research Assistant at Science and Research branch of Azad University, Iran

Yasamin Haririan is a distinguished researcher with a Master’s degree in Medical Engineering (Biomaterials) from Science and Research University and a Bachelor’s in Textile Science Engineering from Amirkabir University of Technology. She has made significant contributions to the field through her patent on advanced wound dressings and multiple research papers in prominent journals. Her research focuses on stem cell engineering, peptide hydrogels, and wound healing technologies. Yasamin’s experience spans roles as a Research Assistant, Teaching Assistant, and Project Assistant, showcasing her hands-on skills and instructional capabilities. Her awards include grants from the Iran Nanotechnology Innovation Council and accolades for her master’s thesis. With a strong foundation in both technical and soft skills, Yasamin demonstrates a solid commitment to her field. To further enhance her profile, increasing her international research impact and improving her English proficiency could be beneficial.

Profile

Education

Yasamin Haririan has a robust educational background in the field of biomaterials and textile science. She completed her M.Sc. in Medical Engineering (Biomaterials) at Science and Research University in Tehran, Iran, from September 2020 to September 2022, graduating with distinction and an impressive GPA of 3.7/4. Her academic performance was further highlighted by a degree classification of 1st. Prior to this, Yasamin earned her B.Sc. in Textile Science Engineering (Textile Technology) from Amirkabir University of Technology (AUT) in Tehran, where she studied from September 2015 to May 2020. Her undergraduate studies included a significant improvement in her last two semesters, achieving a GPA of 3.15/4, reflecting her growing expertise and dedication to her field. This strong academic foundation provided her with the skills and knowledge essential for her research and professional endeavors.

Professional Experience

Yasamin Haririan has demonstrated substantial expertise through her diverse professional experiences. As a Research Assistant since January 2022, she has focused on fabricating electro-spun chitosan-based wound dressings and conducting in vivo tests. She also served as an Instructor in April 2024, teaching Academic Photoshop to graduate and Ph.D. students at Tarbiat Modares University. Her role as an Author Assistant and Editor from February 2021 to April 2023 involved translating and editing scientific content for a book on polyurethanes in medicine. Additionally, Yasamin worked as a Teaching Assistant, managing class projects and homework related to controlled drug release systems and hydrogels. Her project assistantship in May-July 2022 included coordinating a startup on novel skin substitute scaffolds. Furthermore, her internship as a Medical Engineer in 2021 provided hands-on experience in monitoring and maintaining medical devices.

Research Interest

Yasamin Haririan’s research interests primarily focus on advancing biomaterials and regenerative medicine. Her work in stem cell engineering, particularly with mesenchymal stem cells, aims to explore their potential for tissue repair and regeneration. Yasamin is deeply involved in developing peptide hydrogels for bone regeneration, which involves designing and optimizing these materials to enhance their effectiveness in supporting bone growth. Additionally, her research encompasses surface modification techniques and hybrid microparticle/gel systems, which are crucial for improving the performance and functionality of biomaterials. By investigating these areas, Yasamin seeks to contribute to the creation of innovative solutions for wound healing and tissue engineering. Her interdisciplinary approach combines expertise in biomaterials, nanotechnology, and regenerative medicine, reflecting a commitment to addressing complex challenges in these fields and advancing the understanding and application of cutting-edge biomedical technologies.

Research Skills

Yasamin Haririan demonstrates exceptional research skills across multiple areas of biomaterials and medical engineering. Her technical expertise encompasses the preparation and characterization of hydrogels and polymeric scaffolds, advanced cell culture techniques, and comprehensive analysis using methods such as MTT assays, UV-vis spectroscopy, FTIR, and SEM. Yasamin is proficient in designing and fabricating electro-spun wound dressings and bio-composite materials, with a particular focus on integrating natural extracts for enhanced wound healing. Her research contributions are underscored by her work on carboxymethyl chitosan-gelatin-mesoporous silica nanoparticles and the development of novel wound dressings. Yasamin’s skills extend to software proficiency, including Microsoft Office, Adobe Photoshop, and statistical tools like SPSS and GraphPad Prism. Additionally, her ability to manage and implement research projects, combined with effective communication and teamwork, underscores her comprehensive approach to research and development in her field.

Award and Recognition

Yasamin Haririan has garnered notable awards and recognition for her outstanding contributions to the field of biomaterials and medical engineering. She was honored with the “Prominent Published Research Paper” grant from the Iran Nanotechnology Innovation Council in May 2024, acknowledging her impactful research. Yasamin also received the “Top Master’s Thesis” prize during Research Week at Science and Research University in December 2023, celebrating her exceptional master’s thesis work. Additionally, she was awarded the “Prominent Defended Master’s Thesis” grant from the Iran Nanotechnology Innovation Council in October 2023, further recognizing her innovative research. Yasamin’s achievements include being selected as a top Ph.D. candidate in the national entrance exam of Iran for Biomaterials at the Material and Energy Research Center in August 2023. These accolades reflect her significant contributions and dedication to advancing research in her field.

Conclusion

Yasamin Haririan is a highly promising candidate for the “Best Researcher Award.” Her strong academic performance, impressive research contributions, relevant expertise, and recognition through awards highlight her as a dedicated and impactful researcher. Addressing the areas for improvement, such as increasing her research impact and enhancing language proficiency, could further strengthen her candidacy and elevate her profile in the global research community. Overall, Yasamin’s qualifications and achievements make her a compelling candidate for this prestigious award.

Publications Top Notes

Carboxymethyl Chitosan-Gelatin-Mesoporous Silica Nanoparticles Containing Myrtus communis L. Extract as a Novel Transparent Film Wound Dressing

  • Authors: Y. Haririan, A. Asefnejad, H. Hamishehkar, M.R. Farahpour
  • Journal: International Journal of Biological Macromolecules
  • Year: 2023
  • Volume: 253
  • Article Number: 127081